Dr Rejman wrote that there was a lack of good data but that the Ortho and Abbott ELISA tests were not very specific when used prospectively in screening donors. His view was that screening of blood donations for Hepatitis C appeared to be of benefit to recipients but could pose major problems to donors given falsely positive results.